855 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva Growth Stock http://seekingalpha.com/article/3991944-teva-growth-stock?source=feed_tag_israel Jul 27, 2016 - Teva Pharmaceuticals is rapidly expanding on multiple fronts.Huge inroads are in progress to the 115+ billion dollar sales per year Japanese pharmaceutical markets.Latest update on huge 40.5 billion d
Teva prices €4B debt offering http://seekingalpha.com/news/3194652-teva-prices-4b-debt-offering?source=feed_news_all Jul 21, 2016 - Teva Pharmaceutical Industries (TEVA) prices a €4B offering of senior notes. The three tranches are: €1.75B of 0.375% fixed rate senior notes due 2020: 99.
Teva prices notes to fund Allergan deal http://seekingalpha.com/news/3193862-teva-prices-notes-fund-allergan-deal?source=feed_news_all Jul 19, 2016 - Teva Pharmaceutical (TEVA) has successfully priced a debt offering for $15M worth of senior notes, maturing between 2018 and 2046, to help fund its acquisi
Allergan's Teva Update: Relax http://seekingalpha.com/article/3988443-allergans-teva-update-relax?source=feed_sector_healthcare Jul 14, 2016 - Allergan's sale of its generic business to Teva is proceeding.Closing the Teva transaction should be a major catalyst for Allergan shares.Capital allocation plan balances M&A flexibility, debt pay dow
Company News for July 14, 2016 http://www.zacks.com/stock/news/223465/company-news-for-july-14-2016?cid=CS-ZC-FT-223465 Jul 14, 2016 - Companies In The News are: VRX,TEVA,NOK,HCSG
Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain http://www.zacks.com/stock/news/223394/teva-teva-provides-2016-2019-outlook-shares-gain?cid=CS-ZC-FT-223394 Jul 14, 2016 - Teva (TEVA) provided its preliminary outlook for 2016-2019 and expects the Actavis Generics acquisition to go through anytime soon.
Teva to raise billions in bond sale next week http://seekingalpha.com/news/3193153-teva-raise-billions-bond-sale-next-week?source=feed_news_all Jul 14, 2016 - Teva Pharmaceutical (TEVA) will raise between $20B-$25B next week to finance its acquisition of Allergan's (AGN) generics business, Globes reports. The bon
Teva Pharmaceutical's (TEVA) CEO Erez Vigodman on 2016-2019 Preliminary Financial Outlook Call (Transcript) http://seekingalpha.com/article/3988257-teva-pharmaceuticals-teva-ceo-erez-vigodman-2016minus-2019-preliminary-financial-outlook-call?source=feed_tag_israel Jul 13, 2016 - View slideshowTeva Pharmaceutical Industries Limited (NYSE:TEVA) 2016-2019 Preliminary Financial Outlook Conference July 13, 2016, 08:00 AM ET Executives Kevin C. Mannix - Senior Vice President of Inv
Why are Allergan (AGN) and Teva Pharma (TEVA) Stocks Up Today? http://www.zacks.com/stock/news/223342/why-are-allergan-agn-and-teva-pharma-teva-stocks-up-today?cid=CS-ZC-FT-223342 Jul 13, 2016 - On Wednesday, shares of Allergan (AGN) and Teva Pharmaceuticals (TEVA) are both on the rise, up around 2% and 3%, respectively, in morning trading after Teva CEO Erez Vigodman said it expects its $40.5 billion acquisition of Allergan's generics business to close any day.
Teva Pharmaceutical Industries Limited 2016 Q2 - Results - Earnings Call Slides http://seekingalpha.com/article/3988121-teva-pharmaceutical-industries-limited-2016-q2-results-earnings-call-slides?source=feed_tag_israel Jul 13, 2016 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2016 Q2 earnings call.

Pages: 1...787980818283848586

<<<Page 83>